The impairment of hypothalamic insulin and leptin signaling pathways is sufficient to promote hyperphagia, obesity, and type 2 diabetes (T2D) in different genetic rodent models with neuronal ablation of insulin and leptin signaling [1],[3],[4]. Here, INS is linked to type 2 diabetes mellitus.